BRIEF-Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system

Reuters
20 Mar
BRIEF-Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system

March 19 (Reuters) - Insulet Corp PODD.O:

  • INSULET’S RADIANT TRIAL DEMONSTRATES MEANINGFUL GLYCEMIC IMPROVEMENTS WITH THE OMNIPOD® 5 AUTOMATED INSULIN DELIVERY SYSTEM FOLLOWING DIRECT TRANSITION FROM MULTIPLE DAILY INJECTIONS

  • INSULET CORP - NO LIFE-THREATENING ACUTE EVENTS IN RADIANT STUDY

Source text: ID:nBw3vdBWRa

Further company coverage: PODD.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10